1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease : Real-World Evidence From G7 Countries
Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per LU
; Henriksen, Tove
; Soileau, Michael J.
; Rodriguez-Cruz, Ramon
; Isaacson, Stuart H.
; Merola, Aristide
; Lindvall, Susanna
and Domingos, Josefa
, et al.
(2022)
In Neurology and Therapy
11(1).
p.303-318
- Contribution to journal › Article
-
Mark
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
Malaty, Irene A. ; Martinez-Martin, Pablo ; Chaudhuri, K. Ray ; Odin, Per LU
; Skorvanek, Matej
; Jimenez-Shahed, Joohi
; Soileau, Michael J.
; Lindvall, Susanna
; Domingos, Josefa
and Jones, Sarah
, et al.
(2022)
In BMC Neurology
22(1).
- Contribution to journal › Article
- 2021
-
Mark
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease : A Systematic Review
Antonini, Angelo ; Odin, Per LU
; Pahwa, Rajesh
; Aldred, Jason
; Alobaidi, Ali
; Jalundhwala, Yash J.
; Kukreja, Pavnit
; Bergmann, Lars
; Inguva, Sushmitha
and Bao, Yanjun
, et al.
(2021)
In Advances in Therapy
38(6).
p.2854-2890
- Contribution to journal › Scientific review